Search results for "Troponin"

showing 10 items of 187 documents

Reply to letter by Parodi et al. regarding article: Revised clinical diagnostic criteria for Tako-tsubo syndrome: The Tako-tsubo Italian Network prop…

2014

Acute coronary syndromemedicine.medical_specialtyEjection fractionbiologybusiness.industryTako-tsubo Cardiomyopathymedicine.diseaseTroponinCoronary artery diseaseTakotsubo CardiomyopathyInternal medicinebiology.proteinCardiologyMedicineHumansTako tsuboCardiology and Cardiovascular MedicinebusinessDiagnosis-Related GroupsInternational journal of cardiology
researchProduct

Risk stratification in non-ST elevation acute coronary syndromes

2005

Abstract Introduction: In acute coronary syndromes, myocardial damage markers and acute-phase reactants predict adverse cardiac events. The aim of this study was to define the fitted prognostic value of the most widely used variables of necrosis and inflammation as well as of homocysteine. Methods and results: Troponin I, high-sensitivity C-reactive protein, fibrinogen and homocysteine were measured in 515 consecutive patients admitted to our institution for non-ST elevation acute coronary syndrome. The risk for major events (death or nonfatal myocardial infarction) through 6 months of follow-up was analysed. In the univariate analysis, all markers were related to major events ( p 11 mg/l (…

Acute coronary syndromemedicine.medical_specialtyHomocysteinebiologyUnstable anginabusiness.industryST elevationC-reactive proteinmedicine.diseaseTroponinchemistry.chemical_compoundchemistryInternal medicineTroponin Imedicinebiology.proteinCardiologyMyocardial infarctionCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Valor pronóstico de la troponina T en pacientes hospitalizados con angina o infarto sin elevación del segmento ST

2003

Introduction and objectives. Cardiac troponins are highly specific and sensitive for detecting minimal myocardial damage. The aim of our study was to determine the prognostic value of troponinT levels in patients hospitalized for suspected angina or myocardial infarction without STsegment elevation. Patients and method. We recorded the frequency of death, acute myocardial infarction, heart failure, or need for coronary revascularization in the three months after the onset of symptoms in 346 consecutive patients admitted for suspected acute coronary syndrome, excluding those who developed myocardial infarction with persistent ST-segment elevation. Results. Serum troponin T levels were ≥ 0.1 …

Acute coronary syndromemedicine.medical_specialtyTroponin TUnstable anginabusiness.industrymedicine.diseaseChest painAnginaInternal medicineHeart failuremedicineCardiologyMyocardial infarction diagnosisMyocardial infarctionmedicine.symptomCardiology and Cardiovascular MedicinebusinessRevista Española de Cardiología
researchProduct

High-sensitivity troponin T and the risk of recurrent readmissions after hospitalization for acute heart failure

2017

Abstract Objectives High-sensitivity troponin is a biomarker of myocardial damage and is associated with a greater risk of mortality and disease progression in patients with acute heart failure (AHF). However, its relationship with the risk of future readmissions is less known. The aim of this study was to assess the association between ultrasensitive troponin T (TnT-us) values in patients with AHF and the risk of recurrent readmissions in the follow-up. Methods We prospectively included a cohort of 621 consecutive patients with AHF, excluding those patients with acute coronary syndrome. We measured the TnT-us levels obtained during the first medical contact in the emergency department. The…

Acute coronary syndromemedicine.medical_specialtybiologyTroponin Tbusiness.industryGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseRate ratioTroponin03 medical and health sciences0302 clinical medicineInterquartile rangeInternal medicineHeart failureCohortmedicineRisk of mortalitybiology.proteinCardiology030212 general & internal medicinebusinessRevista Clínica Española (English Edition)
researchProduct

0436: Diagnostic value of serial ultrasensible troponin I measurements for acute coronary syndrome identification in cardiac intensive care unit

2014

Introduction ACS diagnosis relies on the detection of an increase or a decrease in troponin levels (delta-TnI) that might be estimated as absolute (delta-TnI-abs) or relative value (delta-TnI-rel). The discriminative cut-off value of delta-TnI to identify ACS in patients admitted in ICU is a matter of debate. Methods We aimed to determine in a monocentric registry the cut-off value of delta-TnI to identify ACS among patients admitted in ICU with a suspicion of acute myocardial ischemia. All the patients had 2 measurements of ultrasensible cTnI (ADVIA Centaur Siemens®; 99th percentile: 0,04 μg/L). Patients were classified in 4 groups: 1) ACS (NSTEMI, UA), 2) Cardiac non coronary diseases (he…

Acute coronary syndromemedicine.medical_specialtybiologybusiness.industrymedicine.diseaseChest painmusculoskeletal systemTroponinPericarditisInternal medicineHeart failureTroponin ImedicineCoronary care unitbiology.proteinCardiologycardiovascular systemMyocardial infarctionmedicine.symptombusinessCardiology and Cardiovascular MedicineArchives of Cardiovascular Diseases Supplements
researchProduct

2020

(1) Background: Knowledge about predictors for the long-time patency of recanalized chronic total coronary occlusions (CTOs) is limited. Evidence from invasive follow-up in the absence of acute coronary syndrome (routine surveillance coronary angiography) is scarce. (2) Methods: In a monocentric-retrospective analysis, we obtained baseline as well as periprocedural data of patients undergoing routine invasive follow-up. We defined target vessel failure (TVF) as a combined primary endpoint, consisting of re-occlusion, restenosis, and target vessel revascularization (TVR). (3) Results: We included 93 consecutive patients (15.1% female) from October 2013 to May 2018. After a follow-up period o…

Acute coronary syndromemedicine.medical_specialtybiologybusiness.industrymedicine.medical_treatmentGeneral Medicine030204 cardiovascular system & hematologyRevascularizationmedicine.diseaseTroponin03 medical and health sciences0302 clinical medicineRestenosisInternal medicineCohortmedicineClinical endpointCardiologybiology.proteinCumulative incidence030212 general & internal medicinebusinessTIMIJournal of Clinical Medicine
researchProduct

Influence of training and a maximal exercise test in analytical variability of muscular, hepatic, and cardiovascular biochemical variables.

2014

Short, middle, and long-term exercise, as well as the relative intensity of the physical effort, may influence a broad array of laboratory results, and it is thereby of pivotal importance to appropriately differentiate the 'physiologic' from the 'pathological' effects of exercise. Therefore, the values of some biomarkers in physically active subjects may be cautiously interpreted since the results may fall outside the conventional reference ranges. It has been demonstrated that middle and long-term endurance and/or strenuous exercise triggers transient elevations of muscular and cardiac biomarkers. However, no data have been published about the effect of short-term maximal exercise test on …

AdultCalcitoninMalemedicine.medical_specialtyCardiac biomarkersCardiovascular biomarkersCalcitonin Gene-Related PeptideClinical BiochemistryPhysical ExertionPhysical medicine and rehabilitationReference ValuesInternal medicineNatriuretic Peptide BrainmedicineCreatine Kinase MB FormHumansAspartate AminotransferasesProtein PrecursorsMuscle SkeletalPathologicalExerciseRelative intensitybiologyL-Lactate Dehydrogenasebusiness.industryC-reactive proteinSkeletal muscleHeartGeneral Medicinegamma-GlutamyltransferaseLaboratory resultsPeptide FragmentsTroponinmedicine.anatomical_structureexercise; laboratory; biomarkersC-Reactive ProteinLiverCardiologybiology.proteinExercise TestPhysical EnduranceMaximal exerciseSedentary BehaviorbusinesslaboratoryBiomarkersScandinavian journal of clinical and laboratory investigation
researchProduct

Decision making in a presumptive case of STEMI-like myocarditis

2015

In youngmales, differential diagnosis during chest pain is not always easy. When ECG findings suggest a cardiac origin of such symptoms, myo-pericarditis is usually themost likely hypothesis, beingmore common than Acute Coronary Syndromes (ACS) in the first decades of life [1]. In the presence of ST segment elevation, Troponin release and ventricular wall motion abnormalities, the diagnosis can be challenging, though. In the young a lowcoronary risk profile and atypical symptoms seldom support a working diagnosis of Coronary Heart Disease (CHD), and, therefore, urgent coronary angiography is not recommended routinely, although cases of early ACS are not so rare. In October 2014 a 26-year-ol…

AdultMaleChest Painmedicine.medical_specialtyMyocarditisCath labClinical Decision-MakingMyocarditiPopulationMyocardial InfarctionCoronary AngiographyChest painElectrocardiographyCoronary thrombosisInternal medicinemedicineMyocardial infarctioneducationCreatine KinaseST depressioneducation.field_of_studybusiness.industrymedicine.diseaseTroponinCardiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessTIMIHumanInternational Journal of Cardiology
researchProduct

Establishing the upper reference limit of Galectin-3 in healthy blood donors

2017

Introduction Galectin-3 (Gal-3) is an independent predictor of poor outcomes and mortality in patients with heart failure (HF). Thus, it has been proposed as a reliable prognostic biomarker for HF. The definition of reference intervals is mandatory for interpreting the findings of experimental studies and encouraging the routine use of biomarkers in clinical practice. To date, no study assessed the reference intervals of Gal-3 and identified the biological variables that affect its concentration in a well-defined healthy population. The aim of this study was to determine the upper reference limit (URL) of Gal-3 in a highly reliable population of healthy subjects. Materials and methods We re…

AdultMalePercentilemedicine.medical_specialtyBlood donorAdolescentGalectin 3PopulationClinical BiochemistryBlood DonorsHeart failure030204 cardiovascular system & hematologyYoung Adult03 medical and health sciences0302 clinical medicineInternal medicineNatriuretic Peptide BrainmedicineHumansGalectin-3Prognostic biomarkergalectin-3; blood donors; heart failure; reference values; upper reference limit (URL)educationAgedImmunoassayeducation.field_of_studybusiness.industryHealthy populationTroponin IBiochemistry (medical)Healthy subjectsMiddle Agedreference valuesmedicine.diseaseOriginal PapersHealthy VolunteersReference intervals030220 oncology & carcinogenesisHeart failurePopulation studyFemaleUpper reference limit (URL)businessBiomarkersReference valueGlomerular Filtration Rate
researchProduct

Myocardial infarction marker levels are influenced by prothrombin and tumor necrosis factor-α gene polymorphisms in young patients.

2012

Polymorphisms of genes encoding key factors for the control and activation of inflammatory response and coagulation cascade regulation may play a role in genetic susceptibility to acute myocardial infarction (AMI). This study sought to analyze the effect of TNF - 308G/A and pro-thrombin (FII) 20210G/A polymorphisms on the laboratory parameters of young patients affected by AMI. Results indicated that TNF - 308A positive genotype frequencies were increased in these patients and that a genetically determined higher production of TNF-alpha is associated in young subjects to a more severe cardiac damage as depicted by higher levels of troponin, Creatine kinase-MB Isoenzyme (mCK-MB) and a signif…

AdultMalePro-thrombinGenotypeImmunologyMyocardial InfarctionSNPSingle-nucleotide polymorphismAcute myocardial infarctionPolymorphism Single NucleotideBiochemistryYoung AdultGene FrequencyGenotypeTroponin IGenetic predispositionCreatine Kinase MB FormHumansImmunology and AllergyMedicineGenetic Predisposition to DiseaseMolecular BiologyAllele frequencyInflammationbiologyTumor Necrosis Factor-alphabusiness.industryAge FactorsFibrinogenHematologyMiddle AgedTroponinTumor necrosis factor-a.TroponinGenotype frequencyImmunologyHaematochemical parameterbiology.proteinProthrombinCreatine kinasebusinessBiomarkers
researchProduct